Home › Companies › CYTOKINETICS INC. › 2024-2025
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and CYTOKINETICS INC.’s Form 8-K, filed May 16, 2025 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of May 14, 2025: 7 items on CYTOKINETICS INC.’s Form 8-K, filed May 16, 2025: 4 approved · 3 passed (calculated).
Notable dissent: 2 directors (14.5%, 12.1% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Explore CYTOKINETICS INC. in the interactive database Compare manager voting policies
These tallies are CYTOKINETICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 16, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: John T. Henderson | 86,834,097 | -- | -- | 14,784,943 | 8,867,164 | 85% | Passed (calculated) | — |
| Elect Director: B. Lynne Parshall | 98,261,990 | -- | -- | 3,357,050 | 8,867,164 | 97% | Passed (calculated) | — |
| Elect Director: Muna Bhanji | 89,316,977 | -- | -- | 12,302,063 | 8,867,164 | 88% | Passed (calculated) | — |
| 2. Approval of the Amendment and Restatement of the Amended and Restated 2004 Equity Incentive Plan to: (i) increase the number of authorized shares reserved for issuance under Amended and Restated 2004 Equity Incentive Plan by 5,000,000 shares of common stock | 97,782,771 | 3,668,240 | 168,029 | -- | 8,867,164 | 96% | Approved | — |
| 3. Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock available for issuance by the Company from 163,000,000 to 326,000,000 shares of common stock | 107,322,080 | 3,009,572 | 154,552 | -- | 0 | 97% | Approved | — |
| 4. Ratification of Selection of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025 | 110,254,216 | 77,441 | 154,547 | -- | 0 | 99.9% | Approved | — |
| 5. Advisory Vote on Executive Compensation | 96,760,272 | 4,607,831 | 250,937 | -- | 8,867,164 | 95% | Approved | — |
Source: CYTOKINETICS INC., Form 8-K, filed with the SEC on May 16, 2025 — read the filing on EDGAR.
See voting trends for Health Care companies, 2024-2025: shareholder support by sector and by company size.
352 asset managers disclosed a vote on at least one CYTOKINETICS INC. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: To elect the three nominees listed below as Class III Directors, each to serve for a three-year term and until their successors are duly elected and qualified: B. Lynne Parshall
CYTOKINETICS INC.’s own tally for this item (“Elect Director: B. Lynne Parshall”): 98,261,990 for, 3,357,050 withheld, per its Form 8-K filed May 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,589,750 | 0 | 0 | 0 | For |
| Fidelity | 10,803,423 | 0 | 0 | 0 | For |
| BlackRock | 8,890,354 | 0 | 0 | 0 | For |
| T. Rowe Price | 6,814,055 | 0 | 0 | 0 | For |
| State Street | 1,639,931 | 0 | 0 | 103 | For |
| Charles Schwab | 1,301,119 | 0 | 0 | 0 | For |
| Capital Group | 1,168,110 | 0 | 0 | 0 | For |
| JPMorgan | 690,288 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 663,281 | 0 | 0 | 0 | For |
| Jackson National | 606,655 | 0 | 0 | 0 | For |
| Aberdeen | 602,421 | 0 | 0 | 0 | For |
| Equitable | 226,839 | 0 | 0 | 330,121 | Mixed |
| AllianceBernstein | 0 | 0 | 0 | 462,473 | Withhold |
| Principal | 330,604 | 0 | 0 | 91,109 | Mixed |
| MUTUAL FUND SERIES TRUST | 382,079 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 360,830 | 0 | 0 | 0 | For |
| Invesco | 315,660 | 0 | 0 | 0 | For |
| Prudential/PGIM | 312,744 | 0 | 0 | 0 | For |
| Goldman Sachs | 309,115 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 294,668 | 0 | 0 | 0 | For |
| TIAA | 287,327 | 0 | 0 | 0 | For |
| American Century | 283,535 | 0 | 0 | 0 | For |
| MFS | 283,495 | 0 | 0 | 0 | For |
| Hartford | 271,135 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 266,738 | Withhold |
Fund voting reports, all 102 managers: 57,455,462 for, 1,195,206 withheld, 0 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RP Management, LLC | 980,392 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 60,450 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 1,040,842 for.
Combines 4 wordings of this item as funds reported it.
85% Majority: yes · of votes cast
Description as filed by funds: To elect the three nominees listed below as Class III Directors, each to serve for a three-year term and until their successors are duly elected and qualified: John T. Henderson
CYTOKINETICS INC.’s own tally for this item (“Elect Director: John T. Henderson”): 86,834,097 for, 14,784,943 withheld, per its Form 8-K filed May 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 85% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,588,907 | 0 | 0 | 843 | For |
| Fidelity | 10,803,423 | 0 | 0 | 0 | For |
| BlackRock | 8,890,354 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,481,661 | 0 | 0 | 5,332,394 | Mixed |
| State Street | 1,639,931 | 0 | 0 | 103 | For |
| Charles Schwab | 1,301,119 | 0 | 0 | 0 | For |
| Capital Group | 1,168,110 | 0 | 0 | 0 | For |
| JPMorgan | 690,288 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 663,281 | 0 | 0 | 0 | For |
| Jackson National | 225,099 | 0 | 0 | 381,556 | Mixed |
| Aberdeen | 0 | 0 | 0 | 602,421 | Withhold |
| Equitable | 226,839 | 0 | 0 | 330,121 | Mixed |
| AllianceBernstein | 0 | 0 | 0 | 462,473 | Withhold |
| Principal | 330,604 | 0 | 0 | 91,109 | Mixed |
| MUTUAL FUND SERIES TRUST | 382,079 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 360,830 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 315,660 | Withhold |
| Prudential/PGIM | 312,744 | 0 | 0 | 0 | For |
| Goldman Sachs | 309,115 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 294,668 | 0 | 0 | 0 | For |
| TIAA | 287,327 | 0 | 0 | 0 | For |
| American Century | 283,535 | 0 | 0 | 0 | For |
| MFS | 283,495 | 0 | 0 | 0 | For |
| Hartford | 271,135 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 266,738 | Withhold |
Fund voting reports, all 102 managers: 50,277,088 for, 8,373,580 withheld, 0 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RP Management, LLC | 980,392 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 60,450 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 1,040,842 for.
Combines 4 wordings of this item as funds reported it.
88% Majority: yes · of votes cast
Description as filed by funds: To elect the three nominees listed below as Class III Directors, each to serve for a three-year term and until their successors are duly elected and qualified: Muna Bhanji
CYTOKINETICS INC.’s own tally for this item (“Elect Director: Muna Bhanji”): 89,316,977 for, 12,302,063 withheld, per its Form 8-K filed May 16, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 88% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,589,750 | 0 | 0 | 0 | For |
| Fidelity | 10,803,423 | 0 | 0 | 0 | For |
| BlackRock | 8,890,354 | 0 | 0 | 0 | For |
| T. Rowe Price | 1,481,661 | 0 | 0 | 5,332,394 | Mixed |
| State Street | 1,640,034 | 0 | 0 | 0 | For |
| Charles Schwab | 1,301,119 | 0 | 0 | 0 | For |
| Capital Group | 1,168,110 | 0 | 0 | 0 | For |
| JPMorgan | 690,288 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 663,281 | 0 | 0 | 0 | For |
| Jackson National | 225,099 | 0 | 0 | 381,556 | Mixed |
| Aberdeen | 602,421 | 0 | 0 | 0 | For |
| Equitable | 226,839 | 0 | 0 | 330,121 | Mixed |
| AllianceBernstein | 0 | 0 | 0 | 462,473 | Withhold |
| Principal | 330,604 | 0 | 0 | 91,109 | Mixed |
| MUTUAL FUND SERIES TRUST | 382,079 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 360,830 | 0 | 0 | 0 | For |
| Invesco | 315,660 | 0 | 0 | 0 | For |
| Prudential/PGIM | 312,744 | 0 | 0 | 0 | For |
| Goldman Sachs | 309,115 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 294,668 | 0 | 0 | 0 | For |
| TIAA | 287,327 | 0 | 0 | 0 | For |
| American Century | 283,535 | 0 | 0 | 0 | For |
| MFS | 283,495 | 0 | 0 | 0 | For |
| Hartford | 271,135 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 0 | 0 | 0 | 266,738 | Withhold |
Fund voting reports, all 102 managers: 51,404,373 for, 7,246,295 withheld, 0 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RP Management, LLC | 980,392 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 60,450 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 1,040,842 for.
97% Approved · of votes cast
Description as filed by funds: TO APPROVE AN AMENDMENT TO CYTOKINETICS, INCORPORATED'S AMENDED AND RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF COMMON AVAILABLE FOR ISSUANCE BY CYTOKINETICS, INCORPORATED FROM 163,000,000 TO 326,000,000 SHARES OF COMMON STOCK.
CYTOKINETICS INC.’s own tally for this item (“3. Approval of an amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock available for issuance by the Company from 163,000,000 to 326,000”): 107,322,080 for, 3,009,572 against — passed, per its Form 8-K filed May 16, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders approved the amendment to the Company's Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock available for issuance by the Company from 163,000,000 to 326,000,000 shares of common stock.”
Support: 97% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,589,750 | 0 | 0 | 0 | For |
| Fidelity | 10,803,423 | 0 | 0 | 0 | For |
| BlackRock | 8,890,354 | 0 | 0 | 0 | For |
| T. Rowe Price | 6,814,055 | 0 | 0 | 0 | For |
| State Street | 1,639,981 | 53 | 0 | 0 | For |
| Charles Schwab | 1,301,119 | 0 | 0 | 0 | For |
| Capital Group | 1,168,110 | 0 | 0 | 0 | For |
| JPMorgan | 690,288 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 663,281 | 0 | 0 | 0 | For |
| Jackson National | 606,655 | 0 | 0 | 0 | For |
| Aberdeen | 602,421 | 0 | 0 | 0 | For |
| Equitable | 556,960 | 0 | 0 | 0 | For |
| AllianceBernstein | 462,473 | 0 | 0 | 0 | For |
| Principal | 421,713 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 382,079 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 360,830 | 0 | 0 | 0 | For |
| Invesco | 315,660 | 0 | 0 | 0 | For |
| Prudential/PGIM | 308,154 | 4,590 | 0 | 0 | For |
| Goldman Sachs | 309,115 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 294,668 | 0 | 0 | 0 | For |
| TIAA | 287,327 | 0 | 0 | 0 | For |
| American Century | 283,535 | 0 | 0 | 0 | For |
| MFS | 283,495 | 0 | 0 | 0 | For |
| Hartford | 271,135 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 266,738 | 0 | 0 | 0 | For |
Fund voting reports, all 99 managers: 58,528,690 for, 56,996 against, 0 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RP Management, LLC | 980,392 | 0 | 0 | 0 | For |
Institutional-manager reports, all 1 managers: 980,392 for.
Combines 2 wordings of this item as funds reported it.
96% Approved · of votes cast
Description as filed by funds: TO APPROVE THE AMENDMENT AND RESTATEMENT OF THE CYTOKINETICS AMENDED AND RESTATED 2004 EQUITY INCENTIVE PLAN TO: (I) INCREASE THE NUMBER OF AUTHORIZED SHARES RESERVED FOR ISSUANCE UNDER SUCH PLAN BY 5,000,000 SHARES OF COMMON STOCK AND (II) PROVIDE FOR LIMITATIONS ON THE MAXIMUM GRANT VALUE THAT NON-EXECUTIVE DIRECTORS MAY RECEIVE UNDER SUCH PLAN OF $1,000,000 FOR ANNUAL GRANTS TO CONTINUING DIRECTORS AND $1,250,000 FOR THE INITIAL GRANT TO NEW DIRECTORS.
CYTOKINETICS INC.’s own tally for this item (“2. Approval of the Amendment and Restatement of the Amended and Restated 2004 Equity Incentive Plan to: (i) increase the number of authorized shares reserved for issuance under Amended and Restated 2004 Equity Incentive ”): 97,782,771 for, 3,668,240 against — passed, per its Form 8-K filed May 16, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders approved the amendment and restatement of the Amended and Restated 2004 Equity Incentive Plan to: (i) increase the number of authorized shares reserved for issuance under the Amended and Restated 2004 Equity Incentive Plan by an additional 5,000,000 shares of common stock and (ii) …”
Support: 96% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,589,750 | 0 | 0 | 0 | For |
| Fidelity | 10,803,423 | 0 | 0 | 0 | For |
| BlackRock | 8,890,354 | 0 | 0 | 0 | For |
| T. Rowe Price | 6,814,055 | 0 | 0 | 0 | For |
| State Street | 1,639,931 | 103 | 0 | 0 | For |
| Charles Schwab | 1,301,119 | 0 | 0 | 0 | For |
| Capital Group | 1,168,110 | 0 | 0 | 0 | For |
| JPMorgan | 690,288 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 663,281 | 0 | 0 | 0 | For |
| Jackson National | 606,655 | 0 | 0 | 0 | For |
| Aberdeen | 602,421 | 0 | 0 | 0 | For |
| Equitable | 556,960 | 0 | 0 | 0 | For |
| AllianceBernstein | 462,473 | 0 | 0 | 0 | For |
| Principal | 421,713 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 382,079 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 360,830 | 0 | 0 | 0 | For |
| Invesco | 315,660 | 0 | 0 | 0 | For |
| Prudential/PGIM | 4,590 | 308,154 | 0 | 0 | Against |
| Goldman Sachs | 309,115 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 294,668 | 0 | 0 | 0 | For |
| TIAA | 287,327 | 0 | 0 | 0 | For |
| American Century | 0 | 283,535 | 0 | 0 | Against |
| MFS | 283,495 | 0 | 0 | 0 | For |
| Hartford | 271,135 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 266,738 | 0 | 0 | 0 | For |
Fund voting reports, all 102 managers: 57,693,977 for, 922,368 against, 34,323 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RP Management, LLC | 980,392 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 60,450 | 0 | 0 | 0 | For |
| Maj Invest Holding A/S | 3,045 | 0 | 0 | 0 | For |
Institutional-manager reports, all 3 managers: 1,043,887 for.
Combines 14 wordings of this item as funds reported it.
95% Approved · of votes cast
Prior year: 96.7% for (May 15, 2024 meeting) ▼ 1.2 pts
Description as filed by funds: To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named executive officers, as disclosed in the Proxy Statement.
CYTOKINETICS INC.’s own tally for this item (“5. Advisory Vote on Executive Compensation”): 96,760,272 for, 4,607,831 against — passed, per its Form 8-K filed May 16, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 5: Advisory Vote on Executive Compensation The stockholders approved, on an advisory basis, the compensation of the named executive officers, as disclosed in the Company's Proxy Statement for the 2025 Annual Meeting of Shareholders.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,588,904 | 846 | 0 | 0 | For |
| Fidelity | 10,803,423 | 0 | 0 | 0 | For |
| BlackRock | 8,890,354 | 0 | 0 | 0 | For |
| T. Rowe Price | 6,814,055 | 0 | 0 | 0 | For |
| State Street | 1,640,034 | 0 | 0 | 0 | For |
| Charles Schwab | 1,301,119 | 0 | 0 | 0 | For |
| Capital Group | 1,168,110 | 0 | 0 | 0 | For |
| JPMorgan | 690,288 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 663,281 | 0 | 0 | 0 | For |
| Jackson National | 606,655 | 0 | 0 | 0 | For |
| Aberdeen | 602,421 | 0 | 0 | 0 | For |
| Equitable | 556,960 | 0 | 0 | 0 | For |
| AllianceBernstein | 462,473 | 0 | 0 | 0 | For |
| Principal | 421,713 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 382,079 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 360,830 | 0 | 0 | 0 | For |
| Invesco | 0 | 315,660 | 0 | 0 | Against |
| Prudential/PGIM | 312,744 | 0 | 0 | 0 | For |
| Goldman Sachs | 309,115 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 294,668 | 0 | 0 | 0 | For |
| TIAA | 287,327 | 0 | 0 | 0 | For |
| American Century | 0 | 283,535 | 0 | 0 | Against |
| MFS | 0 | 283,495 | 0 | 0 | Against |
| Hartford | 271,135 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 266,738 | 0 | 0 | 0 | For |
Fund voting reports, all 102 managers: 57,587,126 for, 1,029,219 against, 34,323 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 11,500,702 | 0 | 0 | 0 | For |
| Fidelity | 9,264,517 | 0 | 0 | 0 | For |
| Wellington | 7,006,503 | 0 | 0 | 0 | For |
| State Street | 4,492,143 | 0 | 0 | 0 | For |
| BlackRock | 4,433,357 | 1,007 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,775,839 | 0 | 0 | 0 | For |
| PICTET ASSET MANAGEMENT SA | 1,644,024 | 0 | 0 | 0 | For |
| ORBIMED ADVISORS LLC | 1,509,205 | 0 | 0 | 0 | For |
| AllianceBernstein | 1,367,513 | 0 | 0 | 0 | For |
| Vestal Point Capital, LP | 1,329,352 | 0 | 0 | 0 | For |
| Charles Schwab | 1,324,192 | 0 | 0 | 0 | For |
| Capital Group | 1,168,119 | 0 | 0 | 0 | For |
| RP Management, LLC | 980,392 | 0 | 0 | 0 | For |
| JPMorgan | 975,256 | 0 | 0 | 0 | For |
| BROWN ADVISORY INC | 917,666 | 0 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 857,530 | 0 | 0 | 0 | For |
| Northern Trust | 763,116 | 0 | 0 | 0 | For |
| Janus Henderson | 750,754 | 0 | 0 | 0 | For |
| Fisher Asset Management, LLC | 711,840 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 705,635 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 700,931 | 0 | 0 | 0 | For |
| Point72 | 697,969 | 0 | 0 | 0 | For |
| JENNISON ASSOCIATES LLC | 606,648 | 0 | 0 | 0 | For |
| Aberdeen | 602,421 | 0 | 0 | 0 | For |
| Sarissa Capital Management LP | 0 | 600,000 | 0 | 0 | Against |
Institutional-manager reports, all 274 managers: 67,578,328 for, 3,728,224 against, 150,984 abstained, 7,185 not voted, 100,100 unknown. Showing the 25 largest; every one is in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Prior year: 99.9% for (May 15, 2024 meeting) unchanged
Description as filed by funds: To ratify the appointment by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Cytokinetics, Incorporated's independent registered public accounting firm for the fiscal year ending December 31, 2025.
CYTOKINETICS INC.’s own tally for this item (“4. Ratification of Selection of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025”): 110,254,216 for, 77,441 against — passed, per its Form 8-K filed May 16, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 4: Ratification of Selection of Ernst & Young LLP as Our Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2025 The stockholders ratified the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company's independent reg…”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 16,589,750 | 0 | 0 | 0 | For |
| Fidelity | 10,803,423 | 0 | 0 | 0 | For |
| BlackRock | 8,890,354 | 0 | 0 | 0 | For |
| T. Rowe Price | 6,814,055 | 0 | 0 | 0 | For |
| State Street | 1,640,034 | 0 | 0 | 0 | For |
| Charles Schwab | 1,301,119 | 0 | 0 | 0 | For |
| Capital Group | 1,168,110 | 0 | 0 | 0 | For |
| JPMorgan | 690,288 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 663,281 | 0 | 0 | 0 | For |
| Jackson National | 606,655 | 0 | 0 | 0 | For |
| Aberdeen | 602,421 | 0 | 0 | 0 | For |
| Equitable | 556,960 | 0 | 0 | 0 | For |
| AllianceBernstein | 462,473 | 0 | 0 | 0 | For |
| Principal | 421,713 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 382,079 | 0 | 0 | 0 | For |
| HARBOR FUNDS | 360,830 | 0 | 0 | 0 | For |
| Invesco | 315,660 | 0 | 0 | 0 | For |
| Prudential/PGIM | 312,744 | 0 | 0 | 0 | For |
| Goldman Sachs | 309,115 | 0 | 0 | 0 | For |
| Brown Advisory Funds | 294,668 | 0 | 0 | 0 | For |
| TIAA | 287,327 | 0 | 0 | 0 | For |
| American Century | 283,535 | 0 | 0 | 0 | For |
| MFS | 283,495 | 0 | 0 | 0 | For |
| Hartford | 271,135 | 0 | 0 | 0 | For |
| AB DISCOVERY GROWTH FUND, INC. | 266,738 | 0 | 0 | 0 | For |
Fund voting reports, all 102 managers: 58,607,855 for, 8,490 against, 34,323 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| RP Management, LLC | 980,392 | 0 | 0 | 0 | For |
| Erste Asset Management GmbH | 60,450 | 0 | 0 | 0 | For |
Institutional-manager reports, all 2 managers: 1,040,842 for.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 118,209,139 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 14.03% |
| 2 | Fidelity | 9.14% |
| 3 | BlackRock | 7.52% |
| 4 | T. Rowe Price | 5.76% |
| 5 | State Street | 1.39% |
| 6 | Charles Schwab | 1.10% |
| 7 | Capital Group | 0.99% |
| 8 | JPMorgan | 0.58% |
| 9 | Columbia Threadneedle | 0.56% |
| 10 | Jackson National | 0.51% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 9.73% |
| 2 | Fidelity | 7.84% |
| 3 | Wellington | 5.93% |
| 4 | State Street | 3.80% |
| 5 | BlackRock | 3.75% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 2.35% |
| 7 | PICTET ASSET MANAGEMENT SA | 1.39% |
| 8 | ORBIMED ADVISORS LLC | 1.28% |
| 9 | AllianceBernstein | 1.16% |
| 10 | Vestal Point Capital, LP | 1.12% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 15,563,778 | 13.17% | Form 13F, quarter ended March 31, 2025 |
| Entities affiliated with BlackRock, Inc. | 15,252,905 | 12.90% | Proxy statement (DEF 14A), proxy filed April 10, 2025 |
| The Vanguard Group | 11,915,821 | 10.08% | Proxy statement (DEF 14A), proxy filed April 10, 2025 |
| Entities affiliated with Fidelity Investments | 11,146,954 | 9.43% | Proxy statement (DEF 14A), proxy filed April 10, 2025 |
| FMR (Fidelity) | 10,316,131 | 8.73% | Form 13F, quarter ended March 31, 2025 |
| Wellington Management | 7,988,740 | 6.76% | Form 13F, quarter ended March 31, 2025 |
| Entities affiliated with Wellington Management Group LLP | 6,530,884 | 5.52% | Proxy statement (DEF 14A), proxy filed April 10, 2025 |
| State Street | 6,085,001 | 5.15% | Form 13F, quarter ended March 31, 2025 |
| T. Rowe Price | 1,993,896 | 1.69% | Form 13F, quarter ended March 31, 2025 |
| Point72 | 1,722,984 | 1.46% | Form 13F, quarter ended March 31, 2025 |
Percentages above are of 118,209,139 shares outstanding, as reported by CYTOKINETICS INC. on its Form 10-K dated December 31, 2024 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At CYTOKINETICS INC.'s shareholder meeting held May 14, 2025, in the 2024-2025 proxy season, 352 asset managers reported votes on at least one of its 7 ballot items in their SEC Form N-PX filings, covering 3,391 separate fund positions. On the most widely held item on that ballot — To approve, on an advisory basis, the compensation of Cytokinetics, Incorporated's named… — CYTOKINETICS INC.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: CYTOKINETICS INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 16, 2025.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CYTOKINETICS INC.’s 10-K dated December 31, 2024. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
CYTOKINETICS INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Proxy Votes Now, “CYTOKINETICS (CYTK) 2025 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/cytokinetics-inc/2025 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.